Ezetimibe Tablet
Product Images NDC 82009-024

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ezetimibe (NDC 82009-024). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ezetimibe Tablets, 10 mg (57cb59f3 D54e 4a2e B6ed B872869d1368 01)

FDA Label Image

Ezetimibe Tablets, 10 mg (57cb59f3 D54e 4a2e B6ed B872869d1368 02)

Ezetimibe Tablets, 10 mg (57cb59f3 D54e 4a2e B6ed B872869d1368 02)
This is the label of a medicine container, containing 500 tablets of ezetimibe, USP, with a strength of 10 mg per tablet. The usual dosage is one tablet a day. The tablets should be stored at 20°C to 25°C and protected from moisture. The medicine is manufactured by Zydus Lifesciences Ltd. in India and distributed by Quallet Pharmaceuticals Health LLC in the Cayman Islands.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.